Search Results 601-610 of 15906 for SC
... SC dosing. However, there was no direct evidence that such SC dosing of ACE910 would prevent spontaneous bleeds occurring in daily life. In this study, we ...
Sponsor Protocol Number: ACCRU-SC-1603. About this study. This randomized phase III trial studies how well oxybutynin chloride works in managing hot flashes ...
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...
Automated methods of image quality control · Automated agents to monitor and trouble shoot electronic imaging devices · Web-based methods for imaging device ...
The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...
Related publications · Hota B, Webb T, Chatrathi A, McAninch E, Lateef O. · Pollock BD, Franco PM, Noe KH, Poe JD, Limper AH, Farrugia G, Ting HH, Dowdy SC.
Pornsuriyasak P, Ranade SC, Li A, Parlato MC, Sims CR, Shulga OV, Stine, Demchenko AV. STICS: Surface-tethered iterative carbohydrate synthesis Chem. Commun ...
... SC, Spears GM, Murray DL, Willrich MAV. Diagnostic Utility of Complement Serology for Atypical Hemolytic Uremic Syndrome. Mayo Clin Proc. 2018 Oct; 93 (10): ...
Sc · Scalacort. Also known as. Hydrocortisone (topical application route) · Scalpcort. Also known as · Scemblix. Also known as · Scheinpharm Amoxicillin. Also known ...
The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.